Showing 9 posts of 129 posts found.

Sutent disappoints in lung cancer

August 24, 2010
Research and Development, Sales and Marketing NSCLC, Pfizer, Sutent, Tarceva

Pfizer’s Sutent has failed to improve overall survival in lung cancer patients when combined with Roche’s Tarceva. Pfizer’s SUN 1087 …

Avastin will remain gold standard for lung cancer to 2018

June 20, 2010
Decision Resources, NSCLC, Roche drug tipped to remain key to treatment, avastin

 Industry analysts Decision Resources believes that Roche’s Avastin plus chemotherapy agents will remain as the gold standard for the treatment …


NICE rejects Tarceva maintenance treatment

June 17, 2010
Sales and Marketing NICE, NSCLC, Roche, Tarceva, lung cancer

Roche’s Tarceva should not be used in lung cancer patients who have already been treated and whose disease remains stable, …

Nexavar fails in lung cancer trial

June 15, 2010
Research and Development Bayer, NSCLC, Nexavar, Onyx

Bayer and Onyx Pharmaceutical’s oncology drug Nexavar has failed to meet its primary endpoint in a phase III study for …

Merck gains rights to cancer treatment

May 10, 2010
Research and Development Ariad Pharmaceuticals, Merck & Co, NSCLC

Merck has acquired an exclusive license for a new cancer drug that’s in trials for a number of different forms …

Antisoma cancer drug fails in phase III

March 29, 2010
Research and Development Antisoma, NSCLC, lung cancer

UK biotech Antisoma has suffered a disappointing late-stage failure with a potential lung cancer treatment it was developing with Novartis. …

Alimta recommended as maintenance therapy

March 1, 2010
Sales and Marketing Alimta, Cancer, NSCLC, lilly

 NICE has recommended Alimta as a maintenance treatment for people with locally advanced or metastatic non-small cell lung cancer. Patients …

Latest news from Datamonitor

June 22, 2007
Research and Development, Sales and Marketing NSCLC, Novartis, Pfizer

 Novartis receives FDA approval for blood pressure medicineNovartis has been granted final FDA approval for Exforge, its high blood pressure …

Latest content